ArticleCancer immunology, immunotherapy : CII2023

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

A S Feils et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.